# Curis Inc: filings

CRIS · Nasdaq · CIK 1108205 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cris.md) · [Financials](/companies/cris/financials.md) · [Filings](/companies/cris/filings.md) · [Insiders](/companies/cris/insiders.md)

## Reports and events: 287 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 272, 8-K 185, 10-Q 53, SC 13G/A 51, DEF 14A 21, 3 19, 10-K 18, DEFA14A 18, SC 13G 18, 424B5 17, CT ORDER 16, CORRESP 15, S-8 15, UPLOAD 14, EFFECT 13, PRE 14A 12, ARS 11, SCHEDULE 13G/A 11, S-3 10, 8-K/A 5, SCHEDULE 13G 5, 4/A 4, 5 3, FWP 3, 10-K/A 2, S-1 2, 10-Q/A 1, 3/A 1, 424B4 1, D 1, DRS 1, POS AM 1, POSASR 1, S-3/A 1, S-3ASR 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:30 ET | [8-K](/filings/0001104659-26-116910.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-116910 |
| 2026-08-14 | 20:02 ET | [10-Q](/filings/0001108205-26-000118.md) | Quarterly report, period 2026-06-30 | 0001108205-26-000118 |
| 2026-08-10 | 21:30 ET | [S-1](/filings/0001108205-26-000109.md) | Registration statement | 0001108205-26-000109 |
| 2026-07-30 | 20:01 ET | [8-K](/filings/0001108205-26-000105.md) | 3.01 Delisting notice | 0001108205-26-000105 |
| 2026-07-02 | 12:56 ET | [8-K](/filings/0001108205-26-000078.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001108205-26-000078 |
| 2026-07-01 | 15:22 ET | [8-K/A](/filings/0001108205-26-000076.md) | 5.03 Amendment to articles or bylaws | 0001108205-26-000076 |
| 2026-07-01 | 12:02 ET | [8-K](/filings/0001108205-26-000074.md) | 5.03 Amendment to articles or bylaws | 0001108205-26-000074 |
| 2026-06-25 | 20:01 ET | [8-K](/filings/0001108205-26-000071.md) | 5.07 Shareholder vote results | 0001108205-26-000071 |
| 2026-06-05 | 13:06 ET | [DEF 14A](/filings/0001108205-26-000068.md) | Proxy statement, period 2026-06-25 | 0001108205-26-000068 |
| 2026-05-22 | 20:02 ET | [8-K](/filings/0001108205-26-000065.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001108205-26-000065 |
| 2026-05-13 | 13:20 ET | [10-Q](/filings/0001108205-26-000061.md) | Quarterly report, period 2026-03-31 | 0001108205-26-000061 |
| 2026-05-12 | 20:01 ET | [8-K](/filings/0001108205-26-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-26-000059 |
| 2026-05-01 | 20:02 ET | [8-K](/filings/0001108205-26-000056.md) | 3.01 Delisting notice | 0001108205-26-000056 |
| 2026-04-21 | 20:52 ET | [DEF 14A](/filings/0001108205-26-000053.md) | Proxy statement, period 2026-05-19 | 0001108205-26-000053 |
| 2026-03-24 | 21:00 ET | [10-K](/filings/0001108205-26-000043.md) | Annual report, period 2025-12-31 | 0001108205-26-000043 |
| 2026-03-19 | 20:09 ET | [8-K](/filings/0001108205-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-26-000030 |
| 2026-03-17 | 21:00 ET | [8-K](/filings/0001108205-26-000016.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001108205-26-000016 |
| 2026-02-19 | 21:12 ET | [DEF 14A](/filings/0001108205-26-000011.md) | Proxy statement, period 2026-03-17 | 0001108205-26-000011 |
| 2026-02-09 | 21:53 ET | [8-K](/filings/0001108205-26-000006.md) | 3.01 Delisting notice | 0001108205-26-000006 |
| 2026-01-08 | 00:50 ET | [8-K](/filings/0001108205-26-000002.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-26-000002 |
| 2025-11-13 | 22:16 ET | [8-K/A](/filings/0001108205-25-000111.md) | 9.01 Financial statements and exhibits | 0001108205-25-000111 |
| 2025-11-06 | 21:09 ET | [10-Q](/filings/0001108205-25-000107.md) | Quarterly report, period 2025-09-30 | 0001108205-25-000107 |
| 2025-11-06 | 21:01 ET | [8-K](/filings/0001108205-25-000105.md) | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-25-000105 |
| 2025-10-24 | 20:02 ET | [8-K](/filings/0001108205-25-000098.md) | 3.01 Delisting notice | 0001108205-25-000098 |
| 2025-08-22 | 20:05 ET | [8-K](/filings/0001108205-25-000093.md) | 3.01 Delisting notice | 0001108205-25-000093 |
| 2025-08-11 | 21:32 ET | [S-1](/filings/0001108205-25-000089.md) | Registration statement | 0001108205-25-000089 |
| 2025-08-08 | 21:29 ET | [8-K](/filings/0001108205-25-000087.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-25-000087 |
| 2025-08-05 | 12:25 ET | [10-Q](/filings/0001108205-25-000080.md) | Quarterly report, period 2025-06-30 | 0001108205-25-000080 |
| 2025-08-05 | 12:07 ET | [8-K](/filings/0001108205-25-000079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-25-000079 |
| 2025-07-02 | 12:43 ET | [8-K](/filings/0001108205-25-000072.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-25-000072 |
| 2025-05-22 | 20:04 ET | [8-K](/filings/0001108205-25-000053.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001108205-25-000053 |
| 2025-05-06 | 12:04 ET | [10-Q](/filings/0001108205-25-000046.md) | Quarterly report, period 2025-03-31 | 0001108205-25-000046 |
| 2025-05-06 | 12:03 ET | [8-K](/filings/0001108205-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-25-000045 |
| 2025-04-10 | 20:26 ET | [DEF 14A](/filings/0001108205-25-000036.md) | Proxy statement, period 2025-05-20 | 0001108205-25-000036 |
| 2025-03-31 | 20:04 ET | [10-K](/filings/0001108205-25-000031.md) | Annual report, period 2024-12-31 | 0001108205-25-000031 |
| 2025-03-31 | 12:06 ET | [8-K](/filings/0001108205-25-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-25-000028 |
| 2025-03-28 | 12:16 ET | [8-K](/filings/0001108205-25-000022.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-25-000022 |
| 2025-02-27 | 21:03 ET | [8-K](/filings/0001108205-25-000020.md) | 3.01 Delisting notice | 0001108205-25-000020 |
| 2024-11-14 | 13:05 ET | [10-Q](/filings/0001108205-24-000072.md) | Quarterly report, period 2024-09-30 | 0001108205-24-000072 |
| 2024-11-14 | 13:03 ET | [8-K](/filings/0001108205-24-000071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-24-000071 |
| 2024-10-30 | 01:59 ET | [8-K](/filings/0001108205-24-000068.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-24-000068 |
| 2024-08-01 | 12:08 ET | [10-Q](/filings/0001108205-24-000062.md) | Quarterly report, period 2024-06-30 | 0001108205-24-000062 |
| 2024-08-01 | 12:05 ET | [8-K](/filings/0001108205-24-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-24-000061 |
| 2024-05-23 | 20:06 ET | [8-K](/filings/0001108205-24-000047.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-24-000047 |
| 2024-05-14 | 20:04 ET | [8-K](/filings/0001108205-24-000035.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001108205-24-000035 |
| 2024-05-07 | 12:30 ET | [10-Q](/filings/0001108205-24-000033.md) | Quarterly report, period 2024-03-31 | 0001108205-24-000033 |
| 2024-05-07 | 12:02 ET | [8-K](/filings/0001108205-24-000032.md) | 2.02 Results of operations | 0001108205-24-000032 |
| 2024-04-10 | 20:15 ET | [DEF 14A](/filings/0001108205-24-000025.md) | Proxy statement, period 2024-05-21 | 0001108205-24-000025 |
| 2024-02-08 | 21:01 ET | [10-K](/filings/0001108205-24-000010.md) | Annual report, period 2023-12-31 | 0001108205-24-000010 |
| 2024-02-08 | 13:01 ET | [8-K](/filings/0001108205-24-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001108205-24-000008 |

Page 1 of 6. [Older](/companies/cris/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.